Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars - Insulet (NASDAQ:PODD)

Summary by Benzinga
Insulet Corporation (NASDAQ:PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance. Fourth-quarter adjusted earnings reached $1.55 per share, beating the consensus of $1.45. The automated insulin delivery technology maker reported sales of $783.8 million, up 31.2% year over year or 29% in constant currency (CC), beating the consensus of $768.69 million, exceeding the h…

1 Articles

BenzingaBenzinga
Center

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars - Insulet (NASDAQ:PODD)

Insulet Corporation (NASDAQ:PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance. Fourth-quarter adjusted earnings reached $1.55 per share, beating the consensus of $1.45. The automated insulin delivery technology maker reported sales of $783.8 million, up 31.2% year over year or 29% in constant currency (CC), beating the consensus of $768.69 million, exceeding the h…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Wednesday, February 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

Billerica icon

Billerica

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal